Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Seltorexant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 20,223Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J&J's drug eases depression and insomnia symptoms in late-stage study
    J&J's drug eases depression and insomnia symptoms in late-stage study

    30 May 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/jjs-treatment-depression-succeeds-late-stage-study-2024-05-29/#:~:text=In%20the%20study%2C%20seltorexant%20met,sleep%20disturbance%20outcomes%20in%20patients.

    REUTERS
    30 May 2024
    Share Share
    Minerva and Royalty Announce Sale of Seltorexant Royalty for up to $155M
    Minerva and Royalty Announce Sale of Seltorexant Royalty for up to $155M

    19 Jan 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/minerva-neurosciences-and-royalty-pharma-announce-sale-of-seltorexant-royalty-for-up-to-155-million/

    BIOSPACE
    19 Jan 2021
    Share Share
    Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen
    Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen

    01 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/01/2056174/0/en/Minerva-Neurosciences-Exercises-Right-to-Opt-Out-of-Agreement-With-Janssen-for-Seltorexant-MIN-202.html#:~:text=(NASDAQ%3A%20NERV)%2C%20a,seltorexant%20(MIN%2D202).

    GLOBENEWSWIRE
    01 Jul 2020
    Share Share
    Minerva's sleep drug bests Ambien, placebo in dose-finding study
    Minerva's sleep drug bests Ambien, placebo in dose-finding study

    24 Jun 2019

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/minerva-s-sleep-drug-bests-ambien-placebo-dose-finding-study

    Amirah Al Idrus FIERCE BIOTECH
    24 Jun 2019
    Share Share
    Minerva claims ‘positive’ PhII data on depression drug while push stock down
    Minerva claims ‘positive’ PhII data on depression drug while push stock down

    14 May 2019

    // Amber Tong ENDPTS

    https://endpts.com/minerva-claims-positive-phii-data-on-depression-drug-while-skeptics-pushes-stock-down/

    Amber Tong ENDPTS
    14 May 2019
    Share Share